Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep82 | Adrenal cortex | ECE2015

Marked hypercholesterolaemia caused by mitotane adjuvant chemotherapy for adrenocortical carcinoma

Yurekli Banu Sarer , Kutbay Nilufer Ozdemir , Altun Ilker , Ozgen Gokhan

Aim: Mitotane (o,p′-DDD) has been used to treat adrenocortical carcinoma (ACC) for several decades. Mitotane is often given in adjuvant setting after surgical resection of ACC and treatment usually lasts 2–3 years to reduce ACC recurrence. The use of mitotane is associated with multiple adverse effects. We herein report a case of marked hypercholesterolemia in a man receiving mitotane as adjuvant chemotherapy for ACC.Case: A 64-year-old man wa...

ea0049ep1194 | Clinical case reports - Thyroid/Others | ECE2017

A case with langerhans cell histiocytosis having papillary microcarcinoma of thyroid: two birds in one nest

Ozisik Hatice , Yurekli Banu Sarer , Kutbay Nilufer Ozdemir , Altun Ilker , Ertan Yesim , Makay Ozer , Ozgen Gokhan

Introduction: Langerhans cell histiocytosis (LHH) is an idiopathic, clonal, pleomorphic, neoplastic disorder characterized by the presence of atypical histiocytic cells which are locally or commonly seen in bone, lung, hypothalamus, liver, lymph nodes, mucocutaneous tissues with damaging them.Case: 58 year-old male patient applied to our clinic due to fatigue. On his physical examination, lymphadenopathy and hepatosplenomegaly were absent. In his history...